Reporting of Randomized Controlled Trials: Will it ever improve?

The quest for delivering the best patient care that we can is one that will never end. There are several facets to this delivery, one of which is using the best available evidence. Randomized Controlled Trials (RCTs) dominate this landscape and feature high in the evidence-based medicine hierarchy and quality reporting of these studies is an ethical imperative. The Consolidated Standards of Reporting Trials (CONSORT) to address quality and transparency of reporting was first published in 1996,[1] and its current avatar is the 2010 statement.[2] The statement also has multiple extensions, some of which include noninferiority, equivalence and cluster designs, Chinese herbal medicine formulas, and extension to randomized pilot and feasibility trials among others.[3